Biomaterials Market

Biomaterials Market worth $68.93 billion by 2030

The report "Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030” is projected to grow from USD 48.36 billion in 2025 and to reach USD 68.93 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.

Browse 908 market data Tables and 50 Figures spread through 663 Pages and in-depth TOC on "Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biomaterials-393.html

The global biomaterials market is experiencing growth, driven by several key factors, including the rising advancements in smart, biocompatible, and 3D-printed biomaterials and increasing advancements in healthcare facilities and systems.

The metallic biomaterials segment accounted for the largest share of the global biomaterials market, by type, in 2024.

Based on type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver, magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon and glass), and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials). The metallic biomaterials segment dominated the market share in 2024, due to the heavy reliance on metals for crafting key medical devices in the cardiovascular, dental, and orthopedic fields. With a growing global geriatric population, demand for these devices is surging, as older adults face heightened risks for orthopedic, dental, ophthalmologic, neurological, and cardiovascular conditions.

Orthopedics is expected to be the fastest-growing application segment.

The global biomaterials market is segmented by application into orthopedic, cardiovascular, dental, plastic surgery, urinary applications, wound healing, tissue engineering, ophthalmology, neurological/central nervous system, and other applications. In 2024, the orthopedic segment claimed the largest share of the global biomaterials market. This dominance stems from surging demand driven by an aging population, rising obesity rates, and active lifestyles that increase injury risks, alongside breakthroughs in bioresorbable implants and 3D-printed custom prosthetics that enhance recovery times and patient outcomes.

North America accounted for the largest regional share in the global biomaterials market in 2024.

North America accounted for the largest share of regional revenues and is the primary engine of growth. The region’s dominance reflects its dense concentration of medical-device and biopharma headquarters, academic medical centers, and specialized surgical and research hospitals, as well as strong FDA oversight and rapid uptake of advanced implant, regenerative, and drug-eluting biomaterial technologies. Large orthopedic, cardiovascular, and dental implant pipelines, robust NIH and venture funding for regenerative medicine, and an active clinical-trials ecosystem further cement the US as the leading biomaterials innovation hub within North America, while Canada contributes a smaller but important share, driven by expanding hospital infrastructure and growing investment in tissue-engineering and polymeric biomaterials manufacturing.

Key players in the North American biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany)

Don’t miss out on business opportunities in Biomaterials Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar

MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Biomaterials Market Size,  Share & Growth Report
Report Code
BT 1556
PR Published ON
3/7/2024
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2026 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home